Last update 01 Nov 2024

iTeos Belgium SA

Subsidiary Company|
Belgium
|
www.iteostherapeutics.com

Overview

Tags

Skin and Musculoskeletal Diseases
Neoplasms
Respiratory Diseases
Small molecule drug
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Top 5 Drug TypeCount
Small molecule drug1
Monoclonal antibody1
Top 5 TargetCount
A2aR(Adenosine A2a receptor)1
TIGIT(T cell immunoglobulin and ITIM domains)1

Related

2
Drugs associated with iTeos Belgium SA
Belrestotug
Target
TIGIT
Mechanism
TIGIT inhibitors
Active Org.
GSK PlcGSK Plc [+3]
Originator Org.
iTeos Therapeutics SA
Active Indication
PD-L1 positive Non-Small Cell Lung Cancer [+8]
Inactive Indication
Relapse multiple myeloma
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Inupadenant
Target
A2aR
Mechanism
A2aR antagonists
Active Org.
iTeos Therapeutics, Inc.iTeos Therapeutics, Inc. [+1]
Originator Org.
ITEOS
Active Indication
Locally Advanced Lung Non-Small Cell Carcinoma [+7]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
11
Clinical Trials associated with iTeos Belgium SA
NCT05403385 / RecruitingPhase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating Efficacy and Safety of Inupadenant in Combination with Carboplatin and Pemetrexed in Adults with Nonsquamous Non-small Cell Lung Cancer Who Have Progressed on Immunotherapy
EUCTR2021-005487-22-BE / Not yet recruitingPhase 2
A randomized, double-blind, placebo-controlled, Phase 2 study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with nonsquamous non-small cell lung cancer who have progressed on immunotherapy.
NCT05289492 / TerminatedPhase 1
Study of EOS884448 Alone, and in Combination with Iberdomide with or Without Dexamethasone, in Participants with Relapsed or Refractory Multiple Myeloma
100 Clinical Results associated with iTeos Belgium SA
Login to view more data
0 Patents (Medical) associated with iTeos Belgium SA
Login to view more data
100 Deals associated with iTeos Belgium SA
Login to view more data
100 Translational Medicine associated with iTeos Belgium SA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Belrestotug
 ( TIGIT )		Melanoma
More
Phase 2 Clinical
Inupadenant
 ( A2aR )		Advanced cancer
More
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free